Scientists use scans to watch experimental cancer drugs in action
NCT ID NCT05068102
Summary
This study aims to understand how two new experimental drugs travel to and gather in tumors in people with advanced head and neck cancer, lung cancer, or melanoma. Participants receive one of the new drugs along with an existing immunotherapy, and doctors use special PET scans to track where the drugs go in the body. The main goal is to gather information on how these drugs are distributed, not to test if they cure the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VU University Medical Center
Amsterdam, 1081HV, Netherlands
Conditions
Explore the condition pages connected to this study.